title: Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B.
authors.affiliation: Sce de Néphrologie, Inserm U 430, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Antoine
authors.forename: A
authors.initials: A
authors.lastname: Landau
authors.forename: V
authors.initials: V
authors.lastname: Menoyo
authors.forename: J P
authors.initials: JP
authors.lastname: Duong
authors.forename: A
authors.initials: A
authors.lastname: Duboust
authors.forename: D
authors.initials: D
authors.lastname: Glotz
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D005260:Female; D006515:Hepatitis B virus / Q000302:isolation & purification; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D016030:Kidney Transplantation; D019259:Lamivudine / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012449:Safety
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D019259:Lamivudine